MED12 and sarcoma: Previous studies, which have analyzed the overexpression of p16 and p53 genes, MED12 gene mutations, c-Myc expression, 4q31 and 18q22 deletions and FH mutations suggest that sarcomas possess a more complex molecular and genetic basis than is currently known or understood.